J.C. Romero, Congress, and passing the steroid buck

Leave a comment

I’ve been accused of being an apologist for players taking steroids. There’s an element of truth to that, I suppose, at least if you equate “not thinking that players who take PEDs are Satan” with being an apologist.  I simply think there are worse offenses in the baseball world, even if some folks disagree.

A big reason for my view of this is that not every player — and I’d argue not any player — who tests positive for PED is some cartoonish evil cheater with black intentions in their heart. Some are a little more brazen than others. Some, however, are just kind of screwed by circumstance.

Case in point: The Phillies’ J.C. Romero. As you’ll recall, he was suspended for 50 games to kick off the season as the result of testing positive for a steroid he took via an over the counter supplement last fall.  You’ll also recall that Romero has sued the supplement maker, claiming that it failed to identify the substances in the product that led to his positive test. That suit is still pending, but Major League Baseball — pursuant to a policy it implemented as the result of extreme Congressional heat — wasn’t all that interested in the details.

What gets lost in all of this is that neither Congress — the prime mover behind baseball’s current PED policy — and Major League Baseball — the enforcer — has clean hands in any of this.  Why? For one thing, Congress itself — with the help of President Clinton — was what allowed the current wild west supplement industry to blossom in the first place when it enacted the Dietary Supplement Health and Education Act of 1994, which basically punted all oversight of the supplement industry to . . . the supplement industry itself.  We should not have been shocked, therefore, when all manner of revolutionary products with all manner of questionable yet unnamed ingredients starting showing up at the GNC.

For its part, Major League Baseball famously lagged in telling the union that the supplement Romero was taking would lead to positive tests, even though it knew so ahead of time, and even though it had pledged to keep the union informed of the latest state of PEDs. Romero, in turn, relied on the union for his information.  Of course the union could have and should have told Romero that he needed to call the Major League Baseball hotline, where he could have gotten the updated information, but they failed to do that.

Upshot: there was a metric crap-ton of stuff that happened which led to Romero getting what amounted to a $1.5 million suspension, almost all of which was more the fault of those who would go after PED users than Romero himself.

Against that backdrop, today we learn that Congress is going to wade back into the fray and think about re-regulating the supplement world. That wading is led by Arlen Specter, who was spurred on, he says, by the Romero case. “We’re looking at whether there’s adequate protection for consumers from getting these supplements which have steroids or steroid-like substances,” Specter said.  Union head Don Fehr added that “players, like everyone else, have no idea what they’re taking.”  Specter is probably right to want to take another look at the supplement industry and review that 1994 deregulation. Fehr is right that players who take over the counter supplements may very well not know what they’e taking, partially due to MLB and the union not giving them good or timely information.

In light of this, it is an inescapable conclusion that the PED and supplement world is not comprised of a landscape in which there are cheaters and non-cheaters, evil and good. It’s a complicated environment, and that’s even before you get into the issue of certain things being legal in one country and not legal in another.

To the extent we as fans have decided otherwise and have adopted the rhetoric of good and evil in the great steroid debate, it’s because those congressional hearings and all that fell out of it set such a tone.  Now even Congress is reconsidering the matter.  Maybe we all should too.

Report: Padres working on trading Andrew Cashner

ST. LOUIS, MO - JULY 21: Starter Derek Norris #3 of the San Diego Padres pitches against the St. Louis Cardinals in the first inning at Busch Stadium on July 21, 2016 in St. Louis, Missouri.  (Photo by Dilip Vishwanat/Getty Images)
Dilip Vishwanat/Getty Images
8 Comments

Jon Morosi of FOX Sports and MLB Network reports that the Padres are working to trade starter Andrew Cashner. He notes that a deal may be consummated before he takes the hill for Tuesday’s start in Toronto against the Blue Jays. The Marlins, Orioles, and Rangers have had reported interest in Cashner.

Cashner is 4-7 with a 4.79 ERA and a 61/27 K/BB ratio in 73 1/3 innings. He missed over three weeks between June 11 and July 2 due to a strained neck.

The right-hander is earning $9.625 million this season and will be eligible for a fourth and final year of arbitration going into 2017.

Nationals activate Ryan Zimmerman from the disabled list

LOS ANGELES, CA - JUNE 22:  Ryan Zimmerman #11 of the Washington Nationals reacts to his run to tie the score 1-1 with the Los Angeles Dodgers during the second inning at Dodger Stadium on June 22, 2016 in Los Angeles, California.  (Photo by Harry How/Getty Images)
Harry How/Getty Images
2 Comments

The Nationals announced on Tuesday that the club activated first baseman Ryan Zimmerman from the 15-day disabled list. Zimmerman had been out since July 7 with a strained rib cage on the left side.

Zimmerman has been inserted in the sixth spot in Tuesday’s lineup against the Indians. The veteran went on the DL with a lackluster .221/.284/.402 triple-slash line with 12 home runs and 38 RBI in 313 plate appearances.

Clint Robinson and Daniel Murphy split time at first base in Zimmerman’s absence, which allowed Trea Turner to get regular playing time at second base. Turner will play center field on Tuesday night.

The Nationals also activated pitcher Sammy Solis from the disabled list. Solis had been out since July 7 with inflammation in his right knee.